BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15960145)

  • 1. Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil.
    Fujieda M; Suzuki K; Sato H; Hattori M; Wada N; Tsuchiya M; Okamoto N; Murata T; Matsudaira M; Shimizu M; Ohta K; Naruse K; Sugihara S; Wakiguchi H
    Clin Nephrol; 2005 Jun; 63(6):437-45. PubMed ID: 15960145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
    Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis.
    Fujii A; Tomizawa K; Arimura Y; Nagasawa T; Ohashi YY; Hiyama T; Mizuno S; Suzuki K
    Clin Nephrol; 2000 Apr; 53(4):242-52. PubMed ID: 10809410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
    Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole.
    Wada N; Mukai M; Kohno M; Notoya A; Ito T; Yoshioka N
    Endocr J; 2002 Jun; 49(3):329-34. PubMed ID: 12201217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population.
    Suzuki K; Kobayashi S; Yamazaki K; Gondo M; Tomizawa K; Arimura Y; Nakabayashi K; Ozaki S; Yoshida M; Yoshida T; Tsusaka N; Muso E; Okazaki T; Hashimoto H
    Microbiol Immunol; 2007; 51(12):1215-20. PubMed ID: 18094540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers.
    Erdbrügger U; Hellmark T; Bunch DO; Alcorta DA; Jennette JC; Falk RJ; Nachman PH
    Kidney Int; 2006 May; 69(10):1799-805. PubMed ID: 16557221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
    Wang C; Gou SJ; Xu PC; Zhao MH; Chen M
    Arthritis Res Ther; 2013; 15(6):R196. PubMed ID: 24252385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN; Hsu TC; Chou HH; Tsay GJ
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule.
    Ye H; Zhao MH; Gao Y; Guo XH; Wang HY
    Clin Exp Immunol; 2004 Oct; 138(1):179-82. PubMed ID: 15373922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of MPO-ANCA subtypes in a patient with propylthiouracil-induced vasculitis with multiple complications.
    Ohta K; Shimizu M; Yokoyama T; Ohta K; Nakai A; Seno A; Kasahara Y; Yachie A; Fujieda M; Koizumi S
    Clin Nephrol; 2007 Nov; 68(5):315-21. PubMed ID: 18044264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil.
    Yamashita Y; Yamane K; Fujikawa R; Okubo M; Kohno N
    Endocr J; 2002 Oct; 49(5):555-9. PubMed ID: 12507274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
    Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K
    Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
    Xu X; Zhao M; Zhang Y; Guo X; Wang H
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):404-7. PubMed ID: 12137604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
    Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propylthiouracil (PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA).
    Nakamori Y; Tominaga T; Inoue Y; Shinohara K
    Intern Med; 2003 Jun; 42(6):529-33. PubMed ID: 12857055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.